Why Quantum BioPharma Ltd.’s (QNTM) Stock Is Up 8.01%
As of Tuesday, May 26, Quantum BioPharma Ltd.’s QNTM share price has surged by 8.01%, which has investors questioning if this is right time to sell.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company’s lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. It also develops FSD-PEA, which is in preparation for Phase 2 trial for the treatment of inflammatory diseases, such as mast cell activation syndrome; Lucid-PSYCH to treat major depressive disorder; and unbuzzd, a dietary supplement for the treatment of alcohol misuse. In addition, the company maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd. was founded in 1998 and is based in Toronto, Canada.
Commentary & Analysis
Why Quantum BioPharma Ltd.’s (QNTM) Stock Is Down 23.81%
As of Tuesday, May 26, Quantum BioPharma Ltd.’s QNTM share price has dipped by 23.81%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Quantum BioPharma Ltd.’s (QNTM) Stock Is Down 12.45%
As of Friday, November 28, Quantum BioPharma Ltd.’s QNTM share price has dipped by 12.45%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Quantum BioPharma Ltd.’s (QNTM) Stock Is Down 14.71%
As of Friday, November 28, Quantum BioPharma Ltd.’s QNTM share price has dipped by 14.71%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Quantum BioPharma Ltd.’s (QNTM) Stock Is Down 5.25%
As of Wednesday, October 22, Quantum BioPharma Ltd.’s QNTM share price has dipped by 5.25%, which has investors questioning if this is right time to buy.Jenna Brashear
Financial Summary
| Share Statistics | QNTM | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $26.4 | $674.5 | 11% |
|
| Shares Out (Mil) | 6.7 | 43.5 | 16% |
|
| Institutional Ownership | 64.6% | 84.6% | 40% |
|
| Float (Mil) | 7.7 | 47.3 | 16% |
|
| Beta | 0.43 | 0.71 | 24% |
|
| Avg Daily Volume (000s) | 106 | 290 | 37% |
|
| Price Change (52-week) |
(77.3%) | 69.3% | 7% |
|
| Growth | QNTM | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 6.7% | na |
|
| Net Income (5yr) | 3.8% | (1.4%) | 45% |
|
| EPS (5yr) | 45.9% | 15.0% | 91 |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | (15.1%) | (15.0%) | 51% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | QNTM | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $317 | na |
|
| Net Income (TTM) (Mil) | ($25) | ($11) | 22% |
|
| EPS (TTM) | ($5.354) | ($0.700) | 7% |
|
| Operating Cash Flow (TTM) (Mil) | ($6) | ($6) | 24% |
|
| Net Cash Flow (TTM) (Mil) | $2 | $5 | 48% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $6 | 0% |
|
| Enterprise Value (Q1) (Mil) | $23 | $536 | 12% |
|
| Valuation | QNTM | Industry Median |
Percentile (All Stocks) |
|
| P/B | 3.09 | 2.80 | 65% |
|
| P/E | na | 17.1 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | QNTM | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 68.1% | na |
|
| Net Margin | na | (1.4%) | na |
|
| ROA | (169.5%) | (24.1%) | 3% |
|
| ROE | (429.6%) | (21.0%) | 2% |
|
| Liabilities to Assets | 57.7% | 32.3% | 51% |
|
| F-Score | 3 | 3 | 18% |
|
Quantum BioPharma Ltd. did not pass any screens on 9/4/2026.
